NGM
CELG

North Growth Management’s Celgene Corp CELG Stock Holding History

North Growth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-178,000
Closed -$16.8M – 47
2019
Q1 		$16.8M Hold
178,000
– – 4.49% 3
2018
Q4 		$11.4M Buy
178,000
+57,000
+47% +$4.21M 3.19% 9
2018
Q3 		$10.9M Hold
121,000
– – 2.75% 15
2018
Q2 		$9.64M Buy
121,000
+33,000
+38% +$2.74M 2.43% 20
2018
Q1 		$7.85M Hold
88,000
– – 2.02% 25
2017
Q4 		$9.18M Buy
+88,000
New +$9.93M 2.4% 20

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

North Growth Management's CELG Position: Q2 2019 in Review

North Growth Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 178,000 shares — an estimated $16.8M sold.

North Growth Management first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $16.8M in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • North Growth Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • North Growth Management sold 178,000 Celgene Corp shares in Q2 2019, an estimated $16.8M.
  • North Growth Management first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
  • North Growth Management's Celgene Corp position peaked at $16.8M in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on North Growth Management's 13F filing for Q2 2019, filed 8 Aug 2019.